Research cutoff: September 13, 2026. Dollar amounts are USD per common share unless stated otherwise. This guide separates declared payments, calculations and unannounced future decisions.
Johnson & Johnson’s latest verified quarterly dividend is $1.34. Three declared payments with 2026 payable dates total $3.98 per common share. The $5.36 annualized rate assumes four equal payments; it is not the confirmed calendar-2026 total or a guaranteed 2027 amount.
JNJ dividend dates for calendar 2026
The January declaration, April increase and July declaration establish the record below. The company also explicitly identifies each listed record date as the ex-dividend date. These are cash dividends on JNJ common shares, not on a separate healthcare security.
On a small screen, swipe the table horizontally. Keyboard users can focus the table region and use the arrow keys.
| Declared | Record and ex-date | Payable | Per share |
|---|---|---|---|
| January 2 | February 24, 2026 | March 10, 2026 | $1.30 |
| April 14 | May 26, 2026 | June 9, 2026 | $1.34 |
| July 15 | August 25, 2026 | September 8, 2026 | $1.34 |
For 100 shares eligible for every listed payment, the gross sum is $398. A fourth payment has not been added to this confirmed ledger. If another $1.34 distribution were later declared for 2026, the four-payment total would be $5.32 per share, not $5.36, because the first payment was lower.
What the 2026 increase tells an income investor
The rate rose by four cents, approximately 3.08% before rounding. The company describes this as a 3.1% increase and its 64 th consecutive year of increases. The historical record provides context about policy, but a consecutive-year count is not a contract obligating the board to maintain a future rate. For 100 shares the increase adds $4 per qualifying quarterly payment.
A transparent JNJ dividend outlook for 2027
On a small screen, swipe the table horizontally. Keyboard users can focus the table region and use the arrow keys.
| Assumed payments | Annual per share | 100 eligible shares |
|---|---|---|
| Four at $1.34 | $5.36 | $536 |
| First at $1.34, next three at hypothetical $1.38 | $5.48 | $548 |
| Four at hypothetical $1.20 | $4.80 | $480 |
The higher and lower rates are scenario inputs with no assigned probability. A four-cent increase only for the last payment would produce $5.40 instead of $5.48. All examples assume four distributions and stable eligible holdings. We leave unannounced 2027 payment dates blank rather than copying the 2026 calendar into a new year.
A healthcare-specific dividend review
Our review separates the cash generation of Innovative Medicine and MedTech from accounting adjustments and other corporate commitments. Product growth can support a distribution, but it must translate into cash after research, manufacturing, acquisitions and other needs. Compare matching reporting periods, and examine whether a payout ratio uses reported earnings or an adjusted measure. Neither ratio is sufficient without understanding the adjustments.
For a pharmaceutical and medical-technology business, the durability of the product portfolio matters more than one quarter’s percentage growth. Ask how upcoming competition, development spending and launch execution affect recurring cash. Legal or acquisition-related cash needs can compete with distributions even when the latest operating quarter looks strong. These are review questions, not a forecast of any specific court outcome or medicine approval.
JNJ splits, stock dividends and “bonus” shares
The official stock-split table lists a 2-for-1 split paid out June 12, 2001 and older actions including a 200% stock dividend in 1967. A 200% stock dividend adds two shares for each existing share, producing three in total. It does not triple the holder’s proportional economic interest. No new 2026 or 2027 ratio or distribution date is verified in this guide.
Historical corporate actions must be interpreted on their original terms. Compare old per-share dividends only after putting them on a consistent split basis. A cash-dividend increase, a split and participation in a reinvestment plan are different events. Reinvested dividends buy shares with cash that would otherwise have been paid out; they are not an additional free distribution.
Budgeting and valuation checks
At an illustrative $200 share price, the $5.36 unchanged-rate scenario implies a 2.68% indicated yield. This is arithmetic, not a live quote or a target price. An investor budgeting expenses should track actual payment months rather than expect one-twelfth of that total every month. Price losses, taxes and concentration can outweigh a seemingly dependable income stream.
Frequently asked questions
Does 64 years of increases guarantee another one?
No. It is a historical description. Future board decisions and the company’s financial position determine future distributions.
Is there a confirmed JNJ bonus issue for 2027?
No such entitlement is verified here. Historical split records are not a forecast of a new event.
Continue your research
Read our stock-split and shareholder research for the wider business context, or compare our September dividend research. A dividend is one part of total return, not protection against a fall in the share price.
LiveTodayStock editorial research. Educational information, not personalized investment advice. Cash examples are gross, exclude taxes and fees, and assume the specified shares qualified for each distribution. Future dividends require board approval.